In young adults 20%-47% cases of stroke is due to cardiac embolism. Cardiac Myxoma is an infrequent cause of embolic stroke in young. We are reporting a case of a ischemic stroke in a young adult of 34 years with a history of recreational drug use who was eventually diagnosed with Left Ventricular Apical Myxoma, Systemic Lupus Erythematous (SLE), Lupus Nephritis, Secondary Anti phospholipid Syndrome, Hyper homocysteinemia, and Dyslipidemia.
Introduction:
Stroke is often considered a disease of older people, but an estimated 10% of patients with stroke are younger than 50 years 1 . Many of them have no risk factors for atherosclerosis and no ultimate clear etiological diagnosis even after a thorough investigation. This diagnostic challenge is one of the main scopes of studying and researching mechanisms of brain ischemia in young adults in addition to the dramatic personal, familial, and socio-economic consequences by affecting individuals at the top of their productive age.
Cardioembolism and cervicocephalic arterial dissection have been established as principal etiological factors of IS in young adults 2 , The proportion of cardioembolic strokes in young adults varies from 20% to one third 3,4. Considered an unusual cause of IS in the young two decades ago 5 , atherosclerosis has gaining projection by recent reports of significant raise in traditional risk factors as hypertension, diabetes, obesity, dyslipidemia and tabagism among hospitalized adolescents and young adults 6. Only 1-4% of IS are related to acquired and genetic thrombophilias, but these numbers seem higher in young adults 7 . The most common acquired thrombophilia associated to IS in the young is antiphospholipid syndrome. Antiphospholipid antibodies, particularly lupus anticoagulant, are an independent risk factor for IS in young adults 8 . Genetic prothrombotic states play an important role in young patients with cerebral venous thrombosis, but thrombophilia alone rarely causes arterial occlusions 9 .
We herein report a case of a young adult male who was diagnosed as having Ischemic stroke with right sided hemiplegia and Left Ventricular Apical Myxoma, as well as multiple other comorbidities, each of which are capable of causing recurrent stroke.
Case report:
A 34 year old non diabetic, normotensive gentleman presented on 17 th , April 2016 with sudden onset right sided weakness and speech difficulty for twelve hours. He had no loss of vision, diplopia or dizziness. He gave no history of headache, vomiting, convulsion or loss of consciousness. On further query, he denied having any rash, arthralgia, chest pain, palpitation, breathlessness, or syncope. He had no relevant family history, but he was a chain smoker (20 pack year) and had a history of Cannabis abuse. Examination revealed he was drowsy with normal vital signs. Neurological examination showed nonfluent aphasia and right hemiplegia .Examination of the other systems revealed no abnormality.
CT scan of the brain (Figure 1 ) showed early signs of infarction the loss of 'insular ribbon' sign. MRI of the brain (Figure 2 ) showed an embolic acute large left MCA territory infarct with midline shifting and effacement of the left lateral ventricles. ECG ( Figure 3 ) showed sinus rhythm with anterolateral ischaemia and Chest X-Ray was normal. CBC: Hb-11.5g/ dL, WBC-9,100/cm 3-, Platelet-1,32,000/cm 3 Investigations to detect risk factors for stroke in young adults done in our patient were S. Homocysteine: 30.1 µmol/l, VDRL: non-reactive, TPHA: non-reactive, Anti phospholipid antibody: 40 U / ml (Positive), ANA: Positive (>1.5), Anti ds DNA: Positive 27 U/ml (>25 U/ml). Toxicology screen for Urine was Positive for Cannabinoids. Further investigations included PBF which showed nonspecific morphology with neutrophilia and thrombocytopenia. Blood culture showed no growth. PT: 13.4 sec; INR: 1.1 . Doppler study of neck vessels revealed: Bilateral mild atherosclerosis with no limitation of flow.The patient was not evaluated for Protien C and ProteinS deficiency.
Macroscopic hematuria and high titre of ANA and positive ds DNA warrented further investigation. Phase contrast microscopy of urine was done and it showed 3-5 RBC/ HPF, (10% dysmorphic). 24 hours urinary total protein estimation was 1.00 gm/day, Ccr: 62 ml/min. USG of whole abdomen showed mild swelling of both kidneys. Renal biopsy (Figure 6 ) revealed mesangial proliferative lupus nephritis (Class-II Lupus nephritis). Serum C3 and C4 levels were within normal range. Vasculitis markers including c-ANCA and p-ANCA were negative.
The patient was initially treated with I.V Mannitol, Aspirin, Pantoprazole, Losartan Potassium, Folic acid , Vitamin B6, Vitamin B12 combination, Atorvastatin and daily physiotherapy. The final treatment was modified after The patient was discharged home with advice to follow up with Echocardiography, PT and INR, S. creatinine and Urine R/M/E. Echocardiogram 6 weeks post discharge revealed a sessile LV apical myxoma of 2cm 2 in size (FIGURE 7). Cardiac surgery consultation was taken at that time and the Surgeon advised to follow-up the patient for another 6 months to see the progression of LV mass. Discussion: Cardiac myxomas, although uncommon are one of commonest primary cardiac tumours and account for 50% primary benign cardiac tumours. 10 The majority of myxomas are in the left atrium (75%) followed by the right atrium (20%). LV myxomas account for only 2.5% of cases 11 .The first description of a primary intracardiac tumor was in 1559, located in the left ventricle 12 . In a review of literature, Mazer and Harrigan reported the first case of LV myxoma diagnosed by 2D echocardiography in 1982 13 . Only 37 cases of left ventricular myxomas have been reported up to 1996 14 and 72 cases up to 2014 15 .In this respect ,our case is an extremely rare one.
Myxomas develop in all age groups. Myxomas are found particularly frequently between the 3rd and 6 th decades of life 16 .
Our patient was a 34 year old male. Patients range from stillborn infants to a 95-year-old woman, with an average age of 24 years 17. In a series of 66 sporadic myxomas, the female-to-male ratio was 2.7:118 15 and 3:1 in one series 19 1 Cardiac myxomas have no typical presentation. Typically, patients are asymptomatic or present with nonspecific signs and symptoms. Some authors call heart neoplasms the great "masqueraders" 20 . The clinical features of LV myxoma are mostly caused by embolization and obstruction to LVOT and systemic manifestations as components of the classical triad, but rarely are present all. However, at least one of the triad symptoms is present. Arrhythmias, conduction disturbances, and LV dysfunction can also be seen 21, 22 .
Embolic phenomena in LV myxoma are more common than LA myxomas, occurring in 64% of patients with LV myxoma 23 .In our case ischemic stroke occurred as embolic phenomenon of myxoma and it was the first manifestation of otherwise asymptomatic myxoma.
Thrombus formation in LV is well-known complication in systolic heart failure (incidence 10-30%) and after acute myocardial infarction (incidence 5-15%) 24 .Hypercoagulable state can lead to ventricular thrombus formation even in the normal heart 25 .Main causes of Inherited thrombophilia are G1691A mutation of factor V gene, G20210A mutation of the prothrombin gene, antithrombin deficiency, protein C and protein S deficiency 26 .LV thrombus formation is also associated with antiphospholipid antibody syndrome (APS)and hypereosinophilic syndrome 27, 28 .Autoimmune disorders like Adamantiadis-Behcet's disease and Systemic lupus erythematosus(SLE), have been suggested to cause left ventricular thrombus formation 29, 30 TEE of our patient demonstrated a thrombus attached to LV myxoma .The co-existence of SLE and Secondary APS could have been the contributing factors.
The most important method in myxoma preoperative diagnostics is transthoracic echocardiography. An additional diagnostic method in unclear diagnostic cases is transesophageal echocardiography 31, 32 .
Echocardiography plays a key role in establishing the diagnosis of patients with cardiac myxomas and thrombi. The differentiation between myxomas and thrombi is important because of the distinct treatment strategy. But it is often difficult to triage one from the other.In our case the trans thoracic and TEE did not reveal the typical features of myxoma -a mobile mass attached by a stalk to the septum. But treatment with anticoagulation for a prolonged period only caused slight reduction in size of the mass; possibly due to resolution of its overlying thrombus.
In contrast to masses in ventricle masses in the atria were deemed to be thrombi because of associated spontaneous echo contrast, location in the left atrial appendage, mitral valvular disease or prosthesis, atrial fibrillation, congestive heart failure, and enlarged left atrial chamber. 33 CT and MRI can be used to differentiate the kind of tumor in right parts of the heart. MRI allows determining more specific tumor localization, its size and spread, tumor position to adjacent organs, and also the histological structure as compared to CT. 34 A pedunculated thrombus moving throughout the cardiac cycle has a high tendency to embolize despite adequate anticoagulation 35 .Treatment for such thrombi has included thrombectomy, anticoagulation, or thrombolysis. Our patient was adequately anticoagulated and is now under the constant supervision of cardiac surgeon for further management.
Echocardiographies of our patient showed that the LV myxoma was sessile smooth surfaced and rounded. Cardiologist and cardiac surgeon both have opted for watchful observation. At present our patient is continuing medical management and is gradually improving neurologically and has not experienced any adverse events.
Most cases obtained complete recovery after tumor resection and histological confirmation can be obtained 36 . Our patient has not yet undergone surgical resection of the cardiac tumour. So histological confirmation of diagnosis has not been done.
